Search Results 61-70 of 40825 for liver damage
In this Q&A, Kirk J. Wangensteen, M.D., Ph.D., explains how researchers are using CRISPR/Cas9 to study and develop new therapies for human liver diseases.
MELD is a reliable measure of mortality risk in patients with end-stage liver disease. Learn more at Mayo Clinic.
History of liver damage or disease, including hepatitis C and gallbladder stones; Being pregnant with multiple babies; Pregnancy at an older age, such as 35 ...
This lung condition causes low oxygen levels and shortness of breath in people who have advanced liver disease.
Liver damage that happens due to hepatitis C raises the risk of liver cancer. Treatment of hepatitis C with DAAs lowers this risk somewhat. But it doesn't ...
Although MASLD is the primary cause of pediatric liver disease, not all children with MASLD have obesity, which makes it critical to diagnose and treat the ...
Acute liver failure. Displaying 10 studies. Bleeding in Hospitalized Patients with Liver Disease Rochester, MN; Jacksonville, FL. The ...
The purpose of this study is to determine whether interventions directed to treat AUD integrated with sAH therapies will improve a composite endpoint of alcohol ...
Understanding the genetic basis for liver disease. Dr. Wangensteen's lab performs genomic analysis of samples to find links between patient genetic makeup and ...
This study is a biobank of specimens and clinical data for use in current and future research to better understand the cholestatic liver diseases primary ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.